197 related articles for article (PubMed ID: 6311758)
1. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
Vierikko P; Kauppila A; Vihko R
Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
[TBL] [Abstract][Full Text] [Related]
2. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium.
Neumannova M; Kauppila A; Vihko R
Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973
[TBL] [Abstract][Full Text] [Related]
3. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of estrogen and progestin receptors in ovarian cancer.
Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors in human ovarian tumors.
Willcocks D; Toppila M; Hudson CN; Tyler JP; Baird PJ; Eastman CJ
Gynecol Oncol; 1983 Oct; 16(2):246-53. PubMed ID: 6313494
[TBL] [Abstract][Full Text] [Related]
6. Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment.
Kauppila A; Vierikko P; Isotalo H; Rönnberg L; Vihko R
Acta Obstet Gynecol Scand Suppl; 1984; 123():45-9. PubMed ID: 6093422
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.
Kauppila A; Isotalo H; Kivinen S; Stenbäck F; Vihko R
Int J Cancer; 1985 Feb; 35(2):157-63. PubMed ID: 3156097
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary.
Jänne O; Kauppila A; Syrjälä P; Vihko R
Int J Cancer; 1980 Feb; 25(2):175-9. PubMed ID: 7390646
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progestin binding in cytosols of ovarian adenocarcinomas.
Holt JA; Caputo TA; Kelly KM; Greenwald P; Chorost S
Obstet Gynecol; 1979 Jan; 53(1):50-8. PubMed ID: 760018
[TBL] [Abstract][Full Text] [Related]
10. Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol.
Vierikko P; Kauppila A; Rönnberg L; Vihko R
Fertil Steril; 1985 Feb; 43(2):218-24. PubMed ID: 2981748
[TBL] [Abstract][Full Text] [Related]
11. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
12. Estradiol and progestin receptors, 17-beta-hydroxysteroid-dehydrogenase and histopathologic grade in endometrial carcinoma.
Ciuffi M; Savino L; Santini D; Buzzoni P; Scarselli G; Mazzei T
Tumori; 1982 Jun; 68(3):217-21. PubMed ID: 6958113
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activators and steroid receptor concentrations in normal, benign, and malignant breast and ovarian tissues.
Isotalo H; Tryggvason K; Vierikko P; Kauppila A; Vihko R
Anticancer Res; 1983; 3(5):331-5. PubMed ID: 6685990
[TBL] [Abstract][Full Text] [Related]
14. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas.
Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL
J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370
[TBL] [Abstract][Full Text] [Related]
16. Improved measurement of androgen receptors in human breast cancer.
Lea OA; Kvinnsland S; Thorsen T
Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
[TBL] [Abstract][Full Text] [Related]
17. Female sex steroid receptors in gynecological malignancies: clinical correlates.
Vihko R; Isotalo H; Kauppila A; Vierikko P
J Steroid Biochem; 1983 Jul; 19(1C):827-32. PubMed ID: 6887902
[TBL] [Abstract][Full Text] [Related]
18. 17 beta-hydroxysteroid dehydrogenase in common epithelial ovarian tumors.
Sasano H; Suzuki T; Niikura H; Kaga K; Sato S; Yajima A; Rainey WE; Nagura H
Mod Pathol; 1996 Apr; 9(4):386-91. PubMed ID: 8729977
[TBL] [Abstract][Full Text] [Related]
19. Estradiol and progesterone receptors in normal ovary and ovarian tumors.
Lantta M
Acta Obstet Gynecol Scand; 1984; 63(6):497-503. PubMed ID: 6507051
[TBL] [Abstract][Full Text] [Related]
20. Subcellular concentrations of estrone, estradiol, androstenedione and 17 beta-hydroxysteroid dehydrogenase (17-beta-OH-SDH) activity in malignant and non-malignant human breast tissues.
Mehta RR; Valcourt L; Graves J; Green R; Das Gupta TK
Int J Cancer; 1987 Sep; 40(3):305-8. PubMed ID: 3040598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
